title: Results of a prospective, randomized double-blind study comparing standard vs low-dose OKT3 induction therapy.
authors.affiliation: University of Tennessee, Memphis 38163.
authors.forename: R
authors.initials: R
authors.lastname: Alloway
authors.forename: M
authors.initials: M
authors.lastname: Kotb
authors.forename: D K
authors.initials: DK
authors.lastname: Hathaway
authors.forename: L W
authors.initials: LW
authors.lastname: Gaber
authors.forename: S R
authors.initials: SR
authors.lastname: Vera
authors.forename: A O
authors.initials: AO
authors.lastname: Gaber
mesh_terms: D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D014184:Transplantation, Homologous
chemical_list: D016853:Muromonab-CD3